Fundz

Wheeler Bio Announces Initial Closing Of Series A Round Supporting New Biologics Drug Substance Gmp Expansion In Oklahoma

PRIVATEOct 04, 2022

Round Type

Series A

Oklahoma CityBiotechnologyHealth CareScience And Engineering

Description

Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in small batch clinical production of biologics and GMP-grade reagents using their open-source platform, Portable CMCTM, today announced the first closing of their Series A financing round. The round was co-led by Charles River Laboratories and Echo Investment Capital with participation from ATUM, Floating Point Advisors, Plains Venture Partners (a subsidiary of i2E), and Pine Ridge Ventures.

Quick answer

Wheeler Bio raised an undisclosed amount in a Series A round, dated October 4, 2022. Wheeler Bio is based in Oklahoma City, Oklahoma, United States.

How much did Wheeler Bio raise?
Wheeler Bio raised an undisclosed amount in a Series A round on October 4, 2022.
What does Wheeler Bio do?
Wheeler Bio is a contract development and manufacturing pioneer who has established the ModularCMC™ platform that enables the rapid translation of antibody-based therapeutics from discovery to clinical studies while..
Where is Wheeler Bio based and how big is it?
Wheeler Bio is based in Oklahoma City, Oklahoma, United States. Fundz records about 75 employees.
Who are the decision-makers at Wheeler Bio?
Fundz holds 1 contact at Wheeler Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as Wheeler Bio that raised within 45 days of this round, from Fundz verified event records.

  • Trait Biosciences Inc. raised $230K (Series A) on November 16, 2022.
  • Appili Therapeutics Inc. raised $14M (Funding Round) on November 14, 2022.
  • Hemispherian AS raised $9.8M (Funding Round) on October 19, 2022.
  • Viome raised $67M (Series C) on October 18, 2022.
  • Variantyx raised $20M on October 18, 2022.
  • Viome raised $67M on September 27, 2022.

Who to call at Wheeler Bio, and when

A new round usually means Wheeler Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Wheeler Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Wheeler Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Wheeler Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Wheeler Bio

Location

120 ROBERT S. KERR AVE., SUITE 701

Oklahoma City, Oklahoma, United States

About

Wheeler Bio is a contract development and manufacturing pioneer who has established the ModularCMC™ platform that enables the rapid translation of antibody-based therapeutics from discovery to clinical studies while ensuring scalability in support of advanced development and commercialization. ModularCMC streamlines the path between drug discovery and clinical manufacturing through well-defined systematic work packages ultimately resulting in cGMP product supported by a comprehensive Common Technical Document (CTD) Module 3 for Investigational New Drug Applications (INDs). Wheeler's High Science/High Touch approach combines cutting edge development and cGMP manufacturing technologies with a deeply experienced scientific team committed to timeline transparency, scientific rigor and a true partnering mindset. Wheeler Bio's mission is to accelerate the translation of drug discoveries into clinical impact for our partners and the patients they seek to serve. 

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Wheeler Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts hidden hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Wheeler Bio's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Wheeler Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.